Healthcare

Image

Europe Gene Synthesis Market – Industry Trends and Forecast to 2029

  • Healthcare
  • Published Report
  • Sep 2022
  • Europe
  • 350 Pages
  • No of Tables: 206
  • No of Figures: 49

Europe Gene Synthesis Market – Industry Trends and Forecast to 2029

Market Size in USD Billion

CAGR - % Diagram

Diagram Forecast Period 2021–2029
Diagram Market Size (Base Year) USD 467.74 Million
Diagram Market Size (Forecast Year) USD 2232.16 Million
Diagram CAGR %

Europe Gene Synthesis Market, By Component (Synthesizer, Consumables, and Software & Services),  Gene Type (Standard Gene, Express Gene, Complex Gene and Others), Gene Synthesis Type (Gene Library Synthesis, and Custom Gene Synthesis), Application (Synthetic Biology, Genetic Engineering, Vaccine Design, Therapeutics Antibodies, and Others), Method  (Solid Phase Synthesis, Chip-Based DNA Synthesis, and PCR-Based Enzyme Synthesis), End User (Academic & Research Institutes, Diagnostics Laboratories, Biotech & Pharmaceutical Companies, and Others), Distribution Channel (Direct Tender, Online Distribution, and Third Party Distributors), Industry Trends and Forecast to 2029.

Europe Gene Synthesis Market Analysis and Insights 

Gene synthesis is the process of creating artificial genes in a lab setting using synthetic biology. The generation of recombinant proteins is one of the numerous applications of recombinant DNA technology, where gene synthesis is emerging as a key instrument. The traditional methods of cloning and mutagenesis are quickly being replaced by de novo gene synthesis, which also enables the production of nucleic acids for which there is no template.

Europe Gene Synthesis Market

Europe Gene Synthesis Market

Europe gene synthesis market is expected to grow in the forecast period of 2022 to 2029. Data Bridge Market Research analyses that the market is growing with a CAGR of 21.1% in the forecast period of 2022 to 2029 and is expected to reach USD 2,232.16 million by 2029 from USD 467.74 million in 2021.

Report Metric

Details

Forecast Period

2022 to 2029

Base Year

2021

Historic Years

2020 (Customizable to 2019 - 2014)

Quantitative Units

Revenue in USD Million

Segments Covered

By Component (Synthesizer, Consumables, and Software & Services),  Gene Type (Standard Gene, Express Gene, Complex Gene and Others), Gene Synthesis Type (Gene Library Synthesis, and Custom Gene Synthesis), Application (Synthetic Biology, Genetic Engineering, Vaccine Design, Therapeutics Antibodies, and Others), Method  (Solid Phase Synthesis, Chip-Based DNA Synthesis, and PCR-Based Enzyme Synthesis), End User (Academic & Research Institutes, Diagnostics Laboratories, Biotech & Pharmaceutical Companies, and Others), Distribution Channel (Direct Tender, Online Distribution, and Third Party Distributors)

Countries Covered

Germany, France, U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium and the Rest of Europe.

Market Players Covered

Trenzyme GmbH, Twist Bioscience, BioCat GmbH (Subsidiary of AddLife AB), Proteogenix, ATG: biosynthetics GmbH, and Merck KGaA, among others.

Market Definition

Gene synthesis refers to the chemical synthesis of DNA strand base-by base. Unlike DNA replication in cells or by Polymerase Chain Reaction (PCR), gene synthesis does not require a template strand. Rather, gene synthesis involves the step-wise addition of nucleotides to a single-stranded molecule, which then serves as a template for creating a complementary strand. Gene synthesis is the fundamental technology upon which the field of synthetic biology has been built.

Gene Synthesis Market Dynamics

This section deals with understanding the market drivers, opportunities, restraints, and challenges. All of this is discussed in detail as below:

Drivers

  • INCREASED PREVALENCE OF CHRONIC INFECTIOUS DISEASES

Bacterial and viral diseases are rapidly expanding due to the rising prevalence of infectious diseases worldwide. As a result, the demand for novel and effective therapies has increased to fight against such deadly diseases. These diseases can be cured using chemical drugs and biological therapies, including gene therapy. By applying genomics, the management of infectious and endemic diseases has been enhanced. It also allows us to understand emerging drug resistance and identify targets for new therapeutics and vaccines. For the treatment of infectious diseases, gene therapy has attracted many researchers as it can be treated by using recombinant DNA technology, DNA &RNA ribozyme, and single chain antibodies.

As the rising prevalence of the chronic infectious disease is increasing globally, the demand for vaccines and effective gene therapy has also risen, which has increased the demand for novel genes with a significant application for research activities and drug and vaccine manufacturing. Thus, the rising prevalence of infectious diseases is acting as the driver for the gene synthesis market growth.

  • RISING ADOPTION OF GENE THERAPY

Gene therapy is an advanced technique that includes the usage of several genes for the prevention of a particular disease type. The technique involves the insertion of genes into patient cells instead of drugs and surgery. Due to increased demand for novel and long-lasting therapy results, the adoption of gene therapy is rising. Gene therapies demand synthetic gene constructs, among other gene products, to accelerate gene therapy development. Due to the rise in genetic diseases, the demand for a proper cure is one major factor, and with the help of gene therapy, a particular disease type can be cured.

Due to the increased demand, leaders are constantly focused on producing gene therapy products, achieving approval, and marketing authorizations.

Lifesaving medicines and therapies are in huge demand to provide quality life to different patients. These rising numbers of patients largely depend upon the gene therapies available to achieve a proper cure. To manufacture gene therapies, synthetic and novel genes are required, which can be achieved by the gene synthesis technique. Thus, the rising adoption of gene therapy is expected to act as a driver for the gene synthesis market.

  • EXPANSION OF SYNTHETIC BIOLOGY

The incorporation of engineering principles into biology is termed synthetic biology. DNA genome can be reassembled with the help of synthetic biology as it involves the chemical synthesis of DNA by combining it with its genome. Oligonucleotides can be constructed in a short period by incorporating the usage of gene synthesis services, software, and consumables. As synthetic biology products' demand increases worldwide, gene synthesis products and services are also increasing.

Thus, due to its effective and innovative products, the demand for synthetic biology products is increasing globally, which is expected to act as a driving factor for the gene synthesis market.

Opportunities

  •   RISING HEALTHCARE EXPENDITURE

Healthcare expenditure has increased worldwide as people's disposable income in various countries is increasing. Moreover, to accomplish the population requirements, government bodies and healthcare organizations are taking the initiative by virtue of accelerating healthcare expenditure.

Also, the strategic initiatives taken by key market players will provide structural integrity and future opportunities for the medical device testing market in the forecast period of 2022-2029.

Restraints/Challenges

  • HIGH COST OF THE GENE SYNTHESIS PROCESS

However, the barriers to the gene synthesis techniques and the high cost of the gene synthesis process in some regions may impede the growth of the gene synthesis procedures hampering the market growth. Additionally, high competition in medical technology industries and long lead time for the overseas qualification can be challenging factors for the growth of the market

This gene synthesis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the gene synthesis market, contact Data Bridge Market Research for an Analyst Brief. Our team will help you make an informed market decision to achieve market growth.

Recent Development

  • In December 2020, Twist Bioscience launched clonal-ready gene fragments to complete the offering of genes. The fragments launched can be used with adapters or without adapters in order to build up the perfect clones. The clonal-ready gene fragments are compatible with the protein expression pathways, enzyme engineering, and gene expression, among others.
  • In 2020, according to an article published in an ACS journal, a total estimated 19.3 million new cancer cases and almost 10.0 million cancer deaths were reported worldwide. This suggests that cancer coverage is suboptimal, and there is a great need to implement high cancer coverage all over the world.

Europe Gene Synthesis Market Scope

Europe gene synthesis market is segmented into component, gene type, gene synthesis type, application, method, end user, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to make strategic decisions to identify core market applications.

Component

  • Synthesizers
  • Consumables
  • Software & services

On the basis of component, the Europe gene synthesis market is segmented into synthesizers, consumables, and software & services.

Gene Type

  • Standard gene
  • Express gene
  • Complex gene
  • Others

On the basis of gene type, the Europe gene synthesis market is segmented into the standard gene, express gene, complex gene, and others.

Gene Synthesis Type

  • Gene library synthesis
  • Custom gene synthesis

On the basis of gene synthesis type, the Europe gene synthesis market is segmented into gene library synthesis, and custom gene synthesis.

Application

  • Synthetic biology,
  • Genetic engineering,
  • Vaccine design,
  • Therapeutics antibodies  
  • Others

On the basis of application, the Europe gene synthesis market is segmented into synthetic biology, genetic engineering, vaccine design, therapeutics antibodies, and others.

Method

  • Solid based synthesis,
  • Chip-based DNA synthesis
  • PCR-based enzyme synthesis

On the basis of the method, the Europe gene synthesis market is segmented into solid based synthesis, chip-based DNA synthesis, and PCR-based enzyme synthesis.

End User

  • Academic & research institutes,
  • Diagnostics laboratories,
  • Biotech & pharmaceutical companies  
  • Others

On the basis of end user, the Europe gene synthesis market is segmented into academic & research institutes, diagnostics laboratories, biotech & pharmaceutical companies, and others.

Distribution Channel

  • Direct tender
  • Online distribution
  • Third party distributors

Gene Synthesis Market

On the basis of distribution channel, the Europe gene synthesis market is segmented into direct tender, online distribution, and third party distributors.

Gene Synthesis Market Regional Analysis/Insights               

The gene synthesis market is analyzed, and market size insights and trends are provided by the country, component, gene type, gene synthesis type, application, method, end user, and distribution channel, as referenced above.

Germany dominates the Europe gene synthesis market in terms of market share and market revenue and will continue to flourish its dominance during the forecast period. This is due to the rising need for the verification and validation of gene synthesis processes in the region, and rapid research development is boosting the market

The country section of the report also provides individual market-impacting factors and changes in regulations in the market that impact the current and future trends of the market. Data points, such as new and replacement sales, country demographics, disease epidemiology, and import-export tariffs, are some of the major pointers used to forecast the market scenario for individual countries. In addition, the presence and availability of global brands and their challenges faced due to high competition from local and domestic brands, and the impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Gene Synthesis Market Share Analysis

The gene synthesis market competitive landscape provides details by the competitors. Details include company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points are only related to the companies focus on the gene synthesis market.

Some of the major players operating in the gene synthesis market are ATDBio Ltd (Subsidiary of Biotage), General Biosystems, Inc., MACROGEN CO., LTD., Boster Biological Technology, Creative Biogene, Bioneer Pacific, exonbio, trenzyme GmbH, Twist Bioscience, BioCat GmbH (Subsidiary of AddLife AB), OriGene Technologies, Inc., Integrated DNA Technologies, Inc. 9Subsidiary of Danaher Corporation), Eurofins Scientific, NZYTech, Lda. - Genes and Enzymes, Ansa Biotechnologies, Inc., Thermo Fisher Scientific, Genescript, Synbio Technologies, Proteogenix, Bio Basic Inc., ATG:biosynthetics GmbH, Merck KGaA, Kaneka Eurogentec S.A, Ginkgo Bioworks, Bbi-lifesciences, Evonetix, ProMab Biotechnologies, Inc., GCC Biotech (INDIA) Pvt. Ltd., CSBio, Azenta US, Inc., and among others.


SKU-

TABLE 1 EUROPE GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 2 EUROPE SOFTWARE & SERVICES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 3 EUROPE CONSUMABLES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 4 EUROPE CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 5 EUROPE SYNTHESIZER IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 6 EUROPE SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 7 EUROPE GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 8 EUROPE STANDARD GENE IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 9 EUROPE COMPLEX GENE IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 10 EUROPE EXPRESS GENE IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 11 EUROPE OTHERS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 12 EUROPE GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 13 EUROPE CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 14 EUROPE CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 15 EUROPE GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 16 EUROPE GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 17 EUROPE GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 18 EUROPE SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 19 EUROPE SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 20 EUROPE GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 21 EUROPE GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 22 EUROPE THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 23 EUROPE THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 24 EUROPE VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 25 EUROPE VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 26 EUROPE OTHERS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 27 EUROPE GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 28 EUROPE PCR-BASED ENZYME SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 29 EUROPE CHIP-BASED DNA SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 30 EUROPE SOLID BASED SYNTHESIS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 31 EUROPE GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 32 EUROPE ACADEMIC & RESEARCH INSTITUTES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 33 EUROPE BIOTECH & PHARMACEUTICAL COMPANIES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 34 EUROPE DIAGNOSTIC LABORATORIES IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 35 EUROPE OTHERS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 36 EUROPE GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 37 EUROPE DIRECT TENDER IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 38 EUROPE ONLINE DISTRIBUTION IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 39 EUROPE THIRD PARTY DISTRIBUTORS IN GENE SYNTHESIS MARKET, BY REGION, 2020-2029 (USD MILLION)

TABLE 40 EUROPE GENE SYNTHESIS MARKET, BY COUNTRY, 2020-2029 (USD MILLION)

TABLE 41 EUROPE GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 42 EUROPE CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 43 EUROPE SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 44 EUROPE GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 45 EUROPE GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 46 EUROPE CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 47 EUROPE GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 48 EUROPE GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 49 EUROPE SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 50 EUROPE GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 51 EUROPE THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 52 EUROPE VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 53 EUROPE GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 54 EUROPE GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 55 EUROPE GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 56 GERMANY GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 57 GERMANY CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 58 GERMANY SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 59 GERMANY GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 60 GERMANY GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 61 GERMANY CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 62 GERMANY GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 63 GERMANY GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 64 GERMANY SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 65 GERMANY GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 66 GERMANY THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 67 GERMANY VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 68 GERMANY GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 69 GERMANY GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 70 GERMANY GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 71 U.K. GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 72 U.K. CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 73 U.K. SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 74 U.K. GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 75 U.K. GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 76 U.K. CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 77 U.K. GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 78 U.K. GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 79 U.K. SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 80 U.K. GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 81 U.K. THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 82 U.K. VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 83 U.K. GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 84 U.K. GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 85 U.K. GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 86 ITALY GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 87 ITALY CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 88 ITALY SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 89 ITALY GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 90 ITALY GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 91 ITALY CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 92 ITALY GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 93 ITALY GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 94 ITALY SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 95 ITALY GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 96 ITALY THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 97 ITALY VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 98 ITALY GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 99 ITALY GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 100 ITALY GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 101 SPAIN GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 102 SPAIN CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 103 SPAIN SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 104 SPAIN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 105 SPAIN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 106 SPAIN CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 107 SPAIN GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 108 SPAIN GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 109 SPAIN SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 110 SPAIN GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 111 SPAIN THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 112 SPAIN VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 113 SPAIN GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 114 SPAIN GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 115 SPAIN GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 116 FRANCE GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 117 FRANCE CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 118 FRANCE SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 119 FRANCE GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 120 FRANCE GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 121 FRANCE CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 122 FRANCE GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 123 FRANCE GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 124 FRANCE SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 125 FRANCE GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 126 FRANCE THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 127 FRANCE VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 128 FRANCE GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 129 FRANCE GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 130 FRANCE GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 131 NETHERLANDS GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 132 NETHERLANDS CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 133 NETHERLANDS SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 134 NETHERLANDS GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 135 NETHERLANDS GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 136 NETHERLANDS CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 137 NETHERLANDS GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 138 NETHERLANDS GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 139 NETHERLANDS SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 140 NETHERLANDS GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 141 NETHERLANDS THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 142 NETHERLANDS VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 143 NETHERLANDS GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 144 NETHERLANDS GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 145 NETHERLANDS GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 146 RUSSIA GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 147 RUSSIA CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 148 RUSSIA SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 149 RUSSIA GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 150 RUSSIA GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 151 RUSSIA CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 152 RUSSIA GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 153 RUSSIA GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 154 RUSSIA SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 155 RUSSIA GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 156 RUSSIA THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 157 RUSSIA VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 158 RUSSIA GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 159 RUSSIA GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 160 RUSSIA GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 161 SWITZERLAND GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 162 SWITZERLAND CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 163 SWITZERLAND SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 164 SWITZERLAND GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 165 SWITZERLAND GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 166 SWITZERLAND CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 167 SWITZERLAND GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 168 SWITZERLAND GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 169 SWITZERLAND SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 170 SWITZERLAND GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 171 SWITZERLAND THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 172 SWITZERLAND VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 173 SWITZERLAND GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 174 SWITZERLAND GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 175 SWITZERLAND GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 176 TURKEY GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 177 TURKEY CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 178 TURKEY SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 179 TURKEY GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 180 TURKEY GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 181 TURKEY CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 182 TURKEY GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 183 TURKEY GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 184 TURKEY SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 185 TURKEY GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 186 TURKEY THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 187 TURKEY VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 188 TURKEY GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 189 TURKEY GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 190 TURKEY GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 191 BELGIUM GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

TABLE 192 BELGIUM CONSUMABLES IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 193 BELGIUM SYNTHESIZER IN GENE SYNTHESIS MARKET, BY TYPE, 2020-2029 (USD MILLION)

TABLE 194 BELGIUM GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 195 BELGIUM GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 196 BELGIUM CUSTOM GENE SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 197 BELGIUM GENE LIBRARY SYNTHESIS IN GENE SYNTHESIS MARKET, BY GENE TYPE, 2020-2029 (USD MILLION)

TABLE 198 BELGIUM GENE SYNTHESIS MARKET, BY APPLICATION, 2020-2029 (USD MILLION)

TABLE 199 BELGIUM SYNTHETIC BIOLOGY IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 200 BELGIUM GENETIC ENGINEERING IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 201 BELGIUM THERAPEUTIC ANTIBODIES IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 202 BELGIUM VACCINE DESIGN IN GENE SYNTHESIS MARKET, BY GENE SYNTHESIS TYPE, 2020-2029 (USD MILLION)

TABLE 203 BELGIUM GENE SYNTHESIS MARKET, BY METHOD, 2020-2029 (USD MILLION)

TABLE 204 BELGIUM GENE SYNTHESIS MARKET, BY END USER, 2020-2029 (USD MILLION)

TABLE 205 BELGIUM GENE SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2020-2029 (USD MILLION)

TABLE 206 REST OF EUROPE GENE SYNTHESIS MARKET, BY COMPONENT, 2020-2029 (USD MILLION)

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

FREQUENTLY ASK QUESTIONS

The Europe Gene Synthesis Market value is expected USD 2,232.16 million by 2029.
The Europe Gene Synthesis Market is to grow at a CAGR of 21.1% during the forecast by 2029.
The major players operating in the market are Trenzyme GmbH, Twist Bioscience, BioCat GmbH (Subsidiary of AddLife AB), Proteogenix, ATG: biosynthetics GmbH, and Merck KGaA, among others.
The major countries covered in the Market are Germany, France, U.K, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Belgium and the Rest of Europe.
Free Sample Report

CHOOSE LICENCE TYPE

  • 4200.00
  • 3500.00
  • 2000.00
  • 5500.00
  • 7500.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials